The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The results from studies in the olfactory bulbectomized (OB) rat model of depression clearly show that the changes in the immune system following bulbectomy are similar to those reported in depressed patients. For example, mitogen‐stimulated lymphocyte proliferation and neutrophil phagocytosis are reduced while monocyte activity is elevated. In the differential white cell (WBC) count, the percentage of neutrophils is increased and the lymphocytes is decreased. In addition, an increase in some of positive acute phase proteins and a decrease in negative actue phase protein albumin are also found in OB rats. The antidepressants, such as serotonin reuptake inhibitors (fluvoxamine and sertraline), the antihistamine terfenadine, the cytokine IL‐2 and neuropeptide Y, which normalize both the brain noradrenergic and serotonergic system, attenuate the hyperactivity of OB rats in both the ‘open field’ and the open arms of the elevated plus‐maze, and reverse the suppression in both lymphocyte proliferation and neutrophil phagocytosis. Antidepressants (desipramine and lithium) which have been shown to normalize the noradrenergic and/or dopaminergic system in OB rats, significantly reverse the hyperactivity of OB rats in the ‘open field’ and the reduced neutrophil phagocytosis. However, most of these antidepressants and endogenous factors fail to normalize the abnormalities in the WBC count. Thymopeptide treatment normalizes the WBC count, the changes in the noradrenergic and serotonergic systems and lymphocyte proliferation but fails to attenuate the hyperactivity in OB rats. The action of thymopeptides on the immune system is direct, while antidepressants and other agents may indirectly affect the immune systems, via neurotransmitters and cytokines. The results from these studies also demonstrate the causal relationship between endogenous factors (such as the thymopeptides, NPY, IL‐2), the sigma ligand JO 1784 and depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519 · cited 1×
“There is agreement that IL-1 produced by macrophages elevates plasma concentrations of CRF, ACTH and corticosterone (Besedovsky et al., 1986; Bernton et al., 1987; Dunn, 1988).”
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 3×
“Recently, the concentrations of cytokines have also been measured in the CSF and blood of patients with affective illness (Katila et al., 1989; Smith, 1991; Maes etal., 1992~).”
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6
Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. H. (1994) · Brain Research · doi:10.1016/0006-8993(94)90006-x · Cited by 439 · cited 1×
“Zalcman et al. (1994) have reported that i.p. and i.v. injection of IL-1, IL-6 and IL-2 significantly affect neurotransmitter concentratipns in the rat brain.”
Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression
Maes, M., Van Der Planken, M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., Schotte, C., & Cosyns, P. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90004-8 · Cited by 186 · cited 1×
“…I-AT) have been reported to be increased in the plasma of depressed patients, while the plasma concentrations of negative acute phase proteins albumin and transferrin have been found to be decreased (Kronfol and House, 1989; Healy et al., 199 1 ; Maes et al., 1992b; Song Dinan and Leonard, 1994).”
Maes, M. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90066-f · Cited by 147
Neutrophilia and lymphopenia in major mood disorders
Darko, D. F., Rose, J., Christian Gillin, J., Golshan, S., & Baird, S. M. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90095-9 · Cited by 70
Cited by
The olfactory bulbectomised rat as a model of depression
Song, C., & Leonard, B. E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.010 · Cited by 698
Self-citationThe olfactory bulbectomized rat as a model of depression: An update
Kelly, J. P., Wrynn, A. S., & Leonard, B. E. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00004-1 · Cited by 662
Self-citationThe recent progress in animal models of depression
Wang, Q., Timberlake, M. A., Prall, K., & Dwivedi, Y. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.008 · Cited by 370
“The brain content of serotonin and 5-HIAA are also significantly reduced and the chronic antidepressant treatments reverse the changes in serotonin and 5-HIAA levels (Jancsar and Leonard, 1984; Lumia et al., 1992; Song and Leonard, 1995).”
The immune system, depression and the action of antidepressants
Leonard, B. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00155-5 · Cited by 333
Self-citationCytokines: abnormalities in major depression and implications for pharmacological treatment
O'Brien, S. M., Scott, L. V., & Dinan, T. G. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.609 · Cited by 320
Metadata
- Authors
- Song, C., & Leonard, B. E.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 1995-01
- Volume
- 10
- Issue
- 1
- Pages
- 7-18
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2018786505
- Cited by
- 50
- References
- 6
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.